This is a working overview of freeze-dried powder, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-06-07 and is reviewed periodically as new material appears.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
Dread Central writer Jay Krieger found that monsters that were "reflective of their singularly unique worlds" were more memorable to him, and felt that there were few better examples of this than the Headcrab. He felt that the zombification they induced was evocative of John Carpenter's The Thing rather than George A. Romero's zombie films. He found the Half-Life 2 iteration of the Headcrab Zombies as particularly shocking, citing how the Headcrab Zombies have muffled screams from the host and, when killed, the Headcrab falls off dead, revealing a face recognizable enough to see the "haunted look of them realizing their fate in their final moments remains". He argued that the zombies of Half-Life served to show the humanity of the Headcrabs' victims. He also believed that the Headcrabs in Ravenholm, particularly the Poison Headcrabs and running zombies, represented how big of a threat Headcrabs could be. Edge staff felt that the running zombie was a memorable video game monster, believing that its "demented wail" was among the most chilling noises in video games. The Headcrab Zombies were described as "walking tragedies" by Rock Paper Shotgun writer Alec Meer, believing that they represented the horror of what zombies are rather than what zombies can do to the player. He appreciated how the game managed to escalate from questioning why the "weak, tiny" Headcrabs were attacking people, to seeing corpses twitching, and finally to seeing someone who was probably still alive but with no control of their body.
Enzyme-linked receptors (or catalytic receptors) are transmembrane receptors that, upon activation by an extracellular ligand, causes enzymatic activity on the intracellular side. Hence a catalytic receptor is an integral membrane protein possessing both enzymatic, catalytic, and receptor functions. They have two important domains, an extra-cellular ligand binding domain and an intracellular domain, which has a catalytic function; and a single transmembrane helix. The signaling molecule binds to the receptor on the outside of the cell and causes a conformational change on the catalytic function located on the receptor inside the cell. Examples of the enzymatic activity include:
The group released one album in 1965 and three albums in 1966. Dino, Desi & Billy albums contained primarily versions of Top 40 songs made popular by others, with new content being minor. The three boys made an appearance in the Dean Martin film Murderers' Row and sang the Boyce & Hart song, "If You're Thinkin' What I'm Thinkin'". From 1966 to 1970, the group continued to release singles, encountering marginal success, which was not altered by a change of label to Columbia Records in 1969. Also in 1969, the group contributed three songs to the soundtrack of the surf film Follow Me. The group received top billing on the soundtrack album, despite the fact that most of the album featured music by composer Stu Phillips. Later in 1969 the group broke up, due in part to Desi joining his mother's television show and Hinsche wishing to commence university studies. The group was never a favorite of the critics. Writing for AllMusic, music critic Richie Unterberger characterized them as a group that "never had an ounce of credibility", with music that was "innocuously bland in the extreme." These sentiments may be contrasted with the fact that the band was well thought of by the Beach Boys, to the extent that Brian Wilson and Hinsche co-wrote one of the band's original songs, and their final single, "Lady Love". That single was released by Reprise Records in 1970, after the group had broken up. Hinsche's sister, Annie, married Carl Wilson and Hinsche himself worked with the Beach Boys as a backing musician for many years.
=== Present day === Pyrite remains in commercial use for the production of sulfur dioxide, for use in such applications as the paper industry, and in the manufacture of sulfuric acid. Thermal decomposition of pyrite into FeS (iron(II) sulfide) and elemental sulfur starts at 540 °C (1,004 °F); at around 700 °C (1,292 °F), pS2 is about 1 atm. A newer commercial use for pyrite is as the cathode material in Energizer brand non-rechargeable lithium metal batteries. Pyrite is a semiconductor material with a band gap of 0.95 eV. Pure pyrite is naturally n-type, in both crystal and thin-film forms, potentially due to sulfur vacancies in the pyrite crystal structure acting as n-dopants. Pyrite has been proposed as an abundant, non-toxic, inexpensive material in low-cost photovoltaic solar panels due to its high absorption of visible light . Synthetic iron sulfide can be used with copper sulfide to create the photovoltaic material. More recent efforts are working toward thin-film solar cells made entirely of pyrite. Pyrite specimens are also very popular in mineral collecting. Among the sites that provide the most sought-after specimens are Soria and La Rioja provinces (Spain). In terms of monetary value, China constitutes the largest market for imported unroasted iron pyrites worldwide, at $47 million, making up 65% of global imports. It is also the fastest growing, with a CAGR of +27.8% from 2007 to 2016.
Sources: en.wikipedia.org
== Composition history == The original commission for Higdon to compose her first opera, in collaboration with Scheer as librettist, came from the San Francisco Opera. Over the period of 2009 to 2011, the creators had searched for various subjects to adapt, which led to the choice of the novel Cold Mountain. However, complications related to securing the rights to adapt the novel, along with conflicts over financial demands and reports of clashes of working style with San Francisco Opera with respect to the creation of new operas, led to the lapsing of this commission. Santa Fe Opera subsequently rescued this commission, in conjunction with the Opera Company of Philadelphia (now Opera Philadelphia) and the Minnesota Opera. Scheer began to write the libretto in autumn 2011, and Higdon began to compose the music in 2012. Higdon used her personal background of having lived in the Appalachia region of the US to assist Scheer with rendering portions of his libretto in a style of speech more authentic to the region, when needed: "I helped Gene 'southernize' the libretto. Gene's from New York, and he wasn't sure how to shape the language for the characters, so I took care of it. Those speech patterns felt very familiar. Scheer estimated that 20 to 25% of the sung text in his libretto came directly from lines in the novel. Higdon took 20 months to complete her score. Workshops of the opera at the Curtis Institute of Music occurred in December 2012 for act 1 and in December 2013 for act 2. In advance of the premiere, four of the five scheduled Santa Fe Opera performances sold out.
== Surveillance == Comparitech Limited, a UK technology advisor, published "The world's most-surveilled cities" in August 2019. It assembled data on the number of closed-circuit television (CCTV) cameras installed in 120 global cities. It then ranked the cities by number of cameras per 1,000 inhabitants. China's cities were found to be the most surveilled. Bangkok was ranked 31 (1=most surveilled; 120=least surveilled), with an estimated 53,429 cameras installed, or 5.16 cameras per 1,000 inhabitants. Other ASEAN cities were ranked: Singapore, 11 (86,000 cameras); Ho Chi Minh City, 72 (6,150 cameras); Yangon, 76 (2,995 cameras); Jakarta, 77 (6,000 cameras); Hanoi, 79 (4,400 cameras); Kuala Lumpur, 106, (1,000 cameras).
Fundamentals of Oncology (1997; co‑editors: Miklós Kásler, István Ember, László Kopper, László Thurzó) Dictionary of Epidemiology (2003; co‑editor: Piroska V. Hajdú) The Health Status of the Hungarian Population at the Turn of the Millennium (2003) Preventive Medicine and Public Health (2006, 2012; first and second editions) Public Health Genomics (2013; co‑editors: Judit Sándor, Angela Brand) Public Health in Budapest (2014; co‑editor: Tamás Szentes) Health Diplomacy (2014; co‑editors: Mihály Kökény, Ilona Kickbusch) Public Health Medicine (2015; co‑editors: István Kárpáti, György Paragh) Preventive Services in Primary Care (2017; co‑editor: Magor Papp) Preventive Medicine and Public Health (third edition, 2023; co‑editors: István Kiss, Edit Paulik, János Sándor, Zoltán Ungvári)
Peptide nucleic acids (PNAs) are synthetic oligonucleotides in which the sugar-phosphate backbone of the DNA or RNA is replaced by a neutral N-(2-aminoethyl)-glycine peptide-like backbone. This allows PNAs to hybridize with complementary DNA or RNA with high affinity and specificity, maintaining their ability to be amplified via polymerase chain reaction (PCR). Unlike DNA/RNA, PNAs are able to resist degradation by nucleases and proteases. In a PNA-encoded library system, unique PNA sequences serve as molecular tags that are covalently attached to small molecules that are produced using combinatorial methods that generate large collections of related compounds. These PNA tags act as barcodes that encode the identity of the PNA allowing for downstream identification. PNA libraries are synthesized using solid-phase peptide synthesis (SPPS), allowing library assembly on resin similar to other peptide libraries. This contrasts with DNA-encoded libraries, which often require enzymatic ligation steps and can be limited by the chemical properties of DNA. The neutrality and stability of the PNA backbone means that PNA tags can tolerate conditions that might degrade DNA tags, and the strong hybridization to complementary nucleic acids which allows PNA tags to be decoded wither by direct hybridization or by conversion into DNA, which can then be amplified and analyzed ,<ref. PNA-encoded libraries have been used in several different formats, including microarray hybridization, selection against biological targets, and PCR-based decoding following selection.
== Interactions == As oxazepam is an active metabolite of diazepam, an overlap in possible interactions is likely with other drugs or food, with exception of the pharmacokinetic CYP450 interactions (e.g. with cimetidine). Precautions and following the prescription are required when taking oxazepam (or other benzodiazepines) in combinations with antidepressants or opioids. Concurrent use of these medications can interact in a way that is difficult to predict. Drinking alcohol when taking oxazepam is not recommended. Concomitant use of oxazepam and alcohol can lead to increased sedation, memory impairment, ataxia, decreased muscle tone, and, in severe cases or in predisposed patients, respiratory depression and coma.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.